Home
Nutraplus India Ltd Share Price History
BSE : 13 Dec, 2021
2.10.1 (5.0%)
Prev Close
2.0
Open Price
1.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
43184
Today's High / Low
2.1 / 1.9
52 WK High / Low
2.1 / 0.0
Market Price of Nutraplus India Ltd
1M
1Y
3Y
5Y
Monitoring Nutraplus India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 102 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -6 |
| BVPS | 19.72 |
Key Financial Parameters
| Parameter | 2012 |
|---|---|
| Return on Capital Emp. % | 20.82 |
| Op. Profit Mgn % | 13.36 |
| Net Profit Mgn % | 6.13 |
| Debt to Equity % | 1.16 |
Latest Shareholding
Promoters Holdings Over Time
About Nutraplus India Ltd
- Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90.
- It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra.
- Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide.
- During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Nutraplus India Ltd's share price history?
Key events that impact Nutraplus India Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Nutraplus India Ltd's share price history?
Stock splits reduce the nominal price of Nutraplus India Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Nutraplus India Ltd?
Dividends can influence Nutraplus India Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Nutraplus India Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Nutraplus India Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Nutraplus India Ltd’s share price history?
To understand Nutraplus India Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
